Evaluation of the “Lose Weight, Gain Life” Program in Anthropometric and Biochemical Parameters
Main Article Content
Abstract
Objective: to analyze the reduction of body weight and the modification of anthropometric and biochemical parameters of the beneficiaries enrolled in the “Pierde Kilos, Gana Vida” program. Methods: cross-sectional analytical study carried out at the General Zone Hospital with Family Medicine No. 1 of the Mexican Institute of Social Security (imss) in Pachuca, Hidalgo. Eighty-three records were reviewed in the database of the aforementioned program, obtained by non-probabilistic convenience sampling, with the following selection criteria: records of patients over 18 years of age, with a diagnosis of overweight and obesity. The study variables were weight, abdominal perimeter, body mass index (bmi), glucose, cholesterol and triglyceride levels at program entry and exit. Inferential statistics were performed with Student’s t and Wilcoxon statistical tests, a value of p<0.05 was considered statistically significant. Results: 78.3% of the participants reduced an average of 3.204 kg (3.81%) of body weight (p= 0.000). 69.88% reduced abdominal perimeter by an average of 5.29 cm (4.51%) (p= 0.000). While 2.41% managed to change their nutritional status to normal weight. More than 50% decreased their glucose, cholesterol and triglyceride levels (p<0.05). Conclusion: the “Lose Weight, Gain Life” program generated significant reductions in weight, abdominal perimeter, bmi and biochemical levels in several participants. Although important results were achieved, there is room for improvement, especially in terms of compliance with program objectives and long-term follow-up.
Downloads
Article Details
Citas en Dimensions Service
References
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-98.
OMS. Obesidad y sobrepeso [Internet]. [citado 2024 May 29]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. 2016;387(10026):1377-96.
Shamah-Levy T, Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, y cols. Encuesta Nacional de Salud y Nutrición 2021 sobre Covid-19. Resultados nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2022.
Instituto Mexicano del Seguro Social. Atención de la obesidad comienza con el control del peso y una revisión periódica sobre el estado de salud. 2020 [Internet]. [citado 2024 May 29]. Disponible en: https://www.imss.gob.mx/prensa/archivo/202002/059
Instituto Nacional de Salud Pública. México y las políticas públicas ante la obesidad [Internet]. [citado 2024 May 30]. Disponible en: https://www.insp.mx/avisos/5091-dia-mundial-obesidad-politicas.html
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875-E891.
Instituto Mexicano del Seguro Social. Lineamientos Programa “Pierde kilos, Gana Vida”, 2021 [Internet]. [citado 2024 May 29]. Disponible en: https://www.imss.gob.mx/prensa/archivo/202211/583.
Secretaría de Salud. NORMA Oficial Mexicana NOM-008-SSA3-2010, Para el tratamiento integral del sobrepeso y la obesidad [Internet]. [citado 2024 May 28]. Disponible en: https://www.dof.gob.mx/normasOficiales/4127/Salud/Salud.htm.
Ramírez RA, Polack PAM. Estadística inferencial. Elección de una prueba estadística no paramétrica en investigación científica. Horizonte de la Ciencia. 2020;10(19):191-208.
Kain ZN, MacLaren J. Valor de p inferior a 0,05: ¿qué significa en realidad? Pediatrics. 2007;63(3)118-20.
Rubio HMA, Moreno LC. Medicina basada en la evidencia: nutrición en la obesidad. Endocrinol Nutr. 2005;52(Supl 2):102-9.
Kaufer-Horwitz M, Pérez HJF. La obesidad: aspectos fisiopatológicos y clínicos. Inter Disciplina. 2022;10(26):147.
Álvarez-Álvarez L, Rubín-García M, Vitelli Storelli F, Fernández-Vázquez JP, Basora J, Fitó M. Efecto de una intervención nutricional intensiva en pacientes refractarios a la pérdida de peso. Med Fam SEMERGEN. 2020;46(3):167-74.
Terapia nutricional médica para la diabetes mellitus tipo 2. [Internet]. [citado 29 mayo24], Disponible en: https://www.uptodate.com/contents/medical-nutrition-therapy-for-type-2-diabetes-mellitus
Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. The Lancet. 2011;378(9786):129-39.
UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group. Metabolism. 1990;39(9):905-12.
Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ. 2010;341:c3337
Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. Nutrition Therapy for Adults with Diabetes or Prediabetes: A Consensus Report. Diabetes Care. 2019;42(5):731-54.
Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, Lee CJ, Bleich SN, Clark JM. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015 Apr 7;162(7):501-512.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.